Literature DB >> 15757562

SARS-associated coronavirus transmitted from human to pig.

Weijun Chen1, Minghua Yan, Ling Yang, Boliang Ding, Bo He, Yingzhen Wang, Xiuli Liu, Chenhui Liu, Hui Zhu, Bo You, Shengyong Huang, Jiangguo Zhang, Feng Mu, Zhao Xiang, Xiaoli Feng, Jie Wen, Jianqiu Fang, Jun Yu, Huanming Yang, Jian Wang.   

Abstract

Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) was isolated from a pig during a survey for possible routes of viral transmission after a SARS epidemic. Sequence and epidemiology analyses suggested that the pig was infected by a SARS-CoV of human origin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757562      PMCID: PMC3298239          DOI: 10.3201/eid1103.040824

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Severe acute respiratory syndrome (SARS) was first identified in Guangdong Province, China, in November 2002 (). A novel coronavirus, SARS-CoV, was identified as the pathogen; several possible origins of the coronavirus were suggested from wild animal reservoirs, such as Himalayan palm civets and raccoon dogs (–). The virus infects many other wild and domesticated animals, such as Mustela furo, Felis domesticus, and Nyctereutes procyonoides (,), but infection of domesticated pigs has not been previously reported.

The Study

We surveyed 6 major domestic animal species that are in close contact with humans and could be infected by SARS-CoV if transmission were possible. The survey was conducted in a suburban area and its extended farming villages, Xiqing County of Tianjin, China, where a SARS outbreak occurred in late spring of 2003. Animal samples, blood and fecal swab specimens, for antibody and RNA detection were collected from the sites and transported on ice to a biosafety level 3 laboratory within 24 hours. We used 2 types of assays for the initial viral screen, immunologic assays to identify antibodies and reverse transcription–polymerase chain reaction (RT-PCR) to detect the viral genome. The immunoassays were carried out by the double-antigen sandwich method with a recombinant N protein and a partial S protein of SARS-CoV, and results were confirmed by Western blot (). RT-PCR with virus-specific primers was used to detect viral genome RNA, which was extracted from blood samples with a QIAamp RNA Blood Mini Kit (Qiagen, Hilden, Germany) and from fecal swabs with Trizol Reagent (Invitrogen, Carlsbad, CA, USA).. Total RNA was then reverse transcribed with random hexamers, and cDNA was amplified with a nested PCR method (). We also isolated viruses from Vero E6 cultures, performed a cross-neutralization test, and sequenced the viral genome (). Of 242 animals surveyed, we identified 2 antibody-positive samples from 2 pigs; test results for the other 240 animals were negative (Table 1 and Figure 1). Of 93 blood specimens and 15 fecal swabs on which we performed RT-PCR, 1 of the same 2 pigs tested positive. We subsequently obtained 2 viral isolates from its blood and fecal samples, designated TJB and TJF, respectively. We also performed follow-up studies for 4 weeks on the infected pig until its blood tested negative with our RT-PCR assay. The animal later died giving birth. We also tested serum samples from the swineherd on the farm and a few persons who may have had contact with the swineherd. All were negative by the tests that we conducted.
Table 1

Animal surveys for antibodies to SARS-CoV and viral RNA*

AnimalsAntibodies in serum samples
RT-PCR
Virus isolation
ELISA
WB
Blood
Fecal swab
Blood
Fecal swab
NPNPNPNPNPNP
Pigs1082521411416161
Cattle60000220000000
Dogs20000140000000
Cats11000110000000
Chickens11000110000000
Ducks30000200000000

*Numbers in table refer to number of animals tested with the assays. SARS-CoV, severe acute respiratory syndrome–associated coronavirus; RT-PCR, reverse transcriptase–polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; WB, Western blot; N, negative; P, positive.

Figure 1

Detection of antibodies against severe acute respiratory syndrome (SARS)–associated coronavirus recombinant proteins in animal sera by Western blotting. Recombinant nuleocapsid protein in panel A (NP, 54 kilodaltons [kDa]) and partial spike protein in panel B (SP, 57 kDa) were used as antigens. Goat anti-swine immunoglobulin G horseradish peroxidase was used as a secondary antibody. Serum samples from a convalescent SARS patient and healthy persons were used as positive and negative controls, respectively. Swine (S1 to S8) and human (H1 and H2) samples are sera collected during the survey. M1, M2, and M3 are purified NP, SP, and molecular weight markers, respectively. Positive bands at the corresponding molecular weight of the 2 proteins are indicated with arrows.

*Numbers in table refer to number of animals tested with the assays. SARS-CoV, severe acute respiratory syndrome–associated coronavirus; RT-PCR, reverse transcriptase–polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; WB, Western blot; N, negative; P, positive. Detection of antibodies against severe acute respiratory syndrome (SARS)–associated coronavirus recombinant proteins in animal sera by Western blotting. Recombinant nuleocapsid protein in panel A (NP, 54 kilodaltons [kDa]) and partial spike protein in panel B (SP, 57 kDa) were used as antigens. Goat anti-swine immunoglobulin G horseradish peroxidase was used as a secondary antibody. Serum samples from a convalescent SARS patient and healthy persons were used as positive and negative controls, respectively. Swine (S1 to S8) and human (H1 and H2) samples are sera collected during the survey. M1, M2, and M3 are purified NP, SP, and molecular weight markers, respectively. Positive bands at the corresponding molecular weight of the 2 proteins are indicated with arrows. Using a viral isolate, TJF, we conducted cross-neutralization experiments with antisera and an early viral isolate, BJ01 (), to prove their equivalent virulence (Table 2). We then sequenced TJF completely (GenBank accession no. AY654624) and compared its sequence to that of BJ01. Eighteen nucleotide (nt) substitutions are between the TJF and BJ01 sequences, and 4 of them are nonsynonymous over the entire length (29,708 bp). Two pieces of evidence strongly suggested a human origin for the TJF strain. First, it is only distantly related to SZ16, which was isolated from Himalayan palm civets of southern China, in which 64 substitutions over a length of 29,731 bp were found, 3.6 times more than were identified between TJF and BJ01. Second, a sequence signature (a 29-nt insertion [246 nt upstream of the N gene, from residues 27869 to 27897]) found only in an early isolate, GD01 (from Guangdong Province), but absent from all the SARS-CoV isolates so far discovered, is also absent in the TJF sequence (). This sequence has been found in all coronavirus isolates of animal origin except from the pig identified in this study. Therefore, direct viral transmission of SARS-CoV from a human host to the pig bearing TJF is most likely. To further elucidate our point, we constructed a phylogenetic tree based on S-gene sequences; it shows that TJF is more closely related to human SARS-CoV isolates than to animal coronaviruses (Figure 2).
Table 2

Cross-neutralization tests for severe acute respiratory syndrome (SARS)–associated coronavirus*

Virus strainsSera (ND50)
S1S2S3H1H2H3
TJF1:1601:640<1:101:1,2801:640–1,280<1:10
BJ011:160–3201:640<1:101:640–1,2801:320–640<1:10

*S1 and S2 were sera from swine that were positive by enzyme-linked immunosorbent assay (ELISA). H1 and H2 were sera from SARS patients. H3 and S3 were controls from sera of a normal human and an ELISA-negative pig, respectively. ND50, 50% neutralization dose.

Figure 2

Phylogenetic analysis of severe acute respiratory syndrome–associated coronavirus S-gene. Nucleotide sequences of S genes (from 21491 to 25258 and 3768 bp in length) were compared. The result was displayed with MEGA-2 program and based on 125 complete S-gene sequences from GenBank.

*S1 and S2 were sera from swine that were positive by enzyme-linked immunosorbent assay (ELISA). H1 and H2 were sera from SARS patients. H3 and S3 were controls from sera of a normal human and an ELISA-negative pig, respectively. ND50, 50% neutralization dose. Phylogenetic analysis of severe acute respiratory syndrome–associated coronavirus S-gene. Nucleotide sequences of S genes (from 21491 to 25258 and 3768 bp in length) were compared. The result was displayed with MEGA-2 program and based on 125 complete S-gene sequences from GenBank.

Conclusions

We have shown that human SARS-CoV can infect domesticated mammals, in particular, the pig. The direct source of SARS-CoV transmission to the identified infected pigs was most likely virus-contaminated animal feed because the farm where the infected pig was identified is rather remote, >1 km from the nearest village. The only person routinely in close contact with the animals is the swineherd, whose serum samples were negative for SARS-CoV on all tests. Swineherds in rural areas often obtain leftovers from restaurants in the cities for use as hogwash (without thoroughly fermenting it). Thus, even if no direct evidence for human-to-swine SARS-CoV transmission exists, a strong warning should be issued to prevent such a practice, or regulatory procedures should be instituted to block this route of disease propagation (). Whether or not other domesticated (such as dogs and cats) and wild animals that are common in and around human settlements can easily contract and pass on SARS-CoV remains to be seen in future studies. Intensive surveillance and investigations on animals, especially during and after an outbreak of SARS, will lead to a better understanding and ability to control this disease’s natural animal reservoirs and to prevent interspecies transmission events.
  11 in total

1.  Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Paul A Rota; M Steven Oberste; Stephan S Monroe; W Allan Nix; Ray Campagnoli; Joseph P Icenogle; Silvia Peñaranda; Bettina Bankamp; Kaija Maher; Min-Hsin Chen; Suxiong Tong; Azaibi Tamin; Luis Lowe; Michael Frace; Joseph L DeRisi; Qi Chen; David Wang; Dean D Erdman; Teresa C T Peret; Cara Burns; Thomas G Ksiazek; Pierre E Rollin; Anthony Sanchez; Stephanie Liffick; Brian Holloway; Josef Limor; Karen McCaustland; Melissa Olsen-Rasmussen; Ron Fouchier; Stephan Günther; Albert D M E Osterhaus; Christian Drosten; Mark A Pallansch; Larry J Anderson; William J Bellini
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

2.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  The Genome sequence of the SARS-associated coronavirus.

Authors:  Marco A Marra; Steven J M Jones; Caroline R Astell; Robert A Holt; Angela Brooks-Wilson; Yaron S N Butterfield; Jaswinder Khattra; Jennifer K Asano; Sarah A Barber; Susanna Y Chan; Alison Cloutier; Shaun M Coughlin; Doug Freeman; Noreen Girn; Obi L Griffith; Stephen R Leach; Michael Mayo; Helen McDonald; Stephen B Montgomery; Pawan K Pandoh; Anca S Petrescu; A Gordon Robertson; Jacqueline E Schein; Asim Siddiqui; Duane E Smailus; Jeff M Stott; George S Yang; Francis Plummer; Anton Andonov; Harvey Artsob; Nathalie Bastien; Kathy Bernard; Timothy F Booth; Donnie Bowness; Martin Czub; Michael Drebot; Lisa Fernando; Ramon Flick; Michael Garbutt; Michael Gray; Allen Grolla; Steven Jones; Heinz Feldmann; Adrienne Meyers; Amin Kabani; Yan Li; Susan Normand; Ute Stroher; Graham A Tipples; Shaun Tyler; Robert Vogrig; Diane Ward; Brynn Watson; Robert C Brunham; Mel Krajden; Martin Petric; Danuta M Skowronski; Chris Upton; Rachel L Roper
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

5.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

6.  Antibody response and viraemia during the course of severe acute respiratory syndrome (SARS)-associated coronavirus infection.

Authors:  Weijun Chen; Zuyuan Xu; Jingsong Mu; Ling Yang; Haixue Gan; Feng Mu; Baoxing Fan; Bo He; Shengyong Huang; Bo You; Yongkui Yang; Xiangjun Tang; Ling Qiu; Yan Qiu; Jie Wen; Jianqiu Fang; Jian Wang
Journal:  J Med Microbiol       Date:  2004-05       Impact factor: 2.472

7.  Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China.

Authors:  Y Guan; B J Zheng; Y Q He; X L Liu; Z X Zhuang; C L Cheung; S W Luo; P H Li; L J Zhang; Y J Guan; K M Butt; K L Wong; K W Chan; W Lim; K F Shortridge; K Y Yuen; J S M Peiris; L L M Poon
Journal:  Science       Date:  2003-09-04       Impact factor: 47.728

8.  A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China.

Authors:  E'de Qin; Xionglei He; Wei Tian; Yong Liu; Wei Li; Jie Wen; Jingqiang Wang; Baochang Fan; Qingfa Wu; Guohui Chang; Wuchun Cao; Zuyuan Xu; Ruifu Yang; Jing Wang; Man Yu; Yan Li; Jing Xu; Bingyin Si; Yongwu Hu; Wenming Peng; Lin Tang; Tao Jiang; Jianping Shi; Jia Ji; Yu Zhang; Jia Ye; Cui'e Wang; Yujun Han; Jun Zhou; Yajun Deng; Xiaoyu Li; Jianfei Hu; Caiping Wang; Chunxia Yan; Qingrun Zhang; Jingyue Bao; Guoqing Li; Weijun Chen; Lin Fang; Changfeng Li; Meng Lei; Dawei Li; Wei Tong; Xiangjun Tian; Jin Wang; Bo Zhang; Haiqing Zhang; Yilin Zhang; Hui Zhao; Xiaowei Zhang; Shuangli Li; Xiaojie Cheng; Xiuqing Zhang; Bin Liu; Changqing Zeng; Songgang Li; Xuehai Tan; Siqi Liu; Wei Dong; Jun Wang; Gane Ka-Shu Wong; Jun Yu; Jian Wang; Qingyu Zhu; Huanming Yang
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-05       Impact factor: 7.691

9.  Virology: SARS virus infection of cats and ferrets.

Authors:  Byron E E Martina; Bart L Haagmans; Thijs Kuiken; Ron A M Fouchier; Guus F Rimmelzwaan; Geert Van Amerongen; J S Malik Peiris; Wilina Lim; Albert D M E Osterhaus
Journal:  Nature       Date:  2003-10-30       Impact factor: 49.962

10.  A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01).

Authors:  E'de Qin; Qingyu Zhu; Man Yu; Baochang Fan; Guohui Chang; Bingyin Si; Bao'an Yang; Wenming Peng; Tao Jiang; Bohua Liu; Yongqiang Deng; Hong Liu; Yu Zhang; Cui'e Wang; Yuquan Li; Yonghua Gan; Xiaoyu Li; Fushuang Lü; Gang Tan; Wuchun Cao; Ruifu Yang; Jian Wang; Wei Li; Zuyuan Xu; Yan Li; Qingfa Wu; Wei Lin; Weijun Chen; Lin Tang; Yajun Deng; Yujun Han; Changfeng Li; Meng Lei; Guoqing Li; Wenjie Li; Hong Lü; Jianping Shi; Zongzhong Tong; Feng Zhang; Songgang Li; Bin Liu; Siqi Liu; Wei Dong; Jun Wang; Gane K-S Wong; Jun Yu; Huanming Yang
Journal:  Chin Sci Bull       Date:  2003
View more
  50 in total

1.  Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy.

Authors:  Dale L Barnard; Yohichi Kumaki
Journal:  Future Virol       Date:  2011-05       Impact factor: 1.831

2.  Analysis of SARS-CoV receptor activity of ACE2 orthologs.

Authors:  Emily R Olivieri; Lindsey K Heller; Laura Gillim-Ross; David E Wentworth
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 3.  Coronavirus Disease 2019-COVID-19.

Authors:  Kuldeep Dhama; Sharun Khan; Ruchi Tiwari; Shubhankar Sircar; Sudipta Bhat; Yashpal Singh Malik; Karam Pal Singh; Wanpen Chaicumpa; D Katterine Bonilla-Aldana; Alfonso J Rodriguez-Morales
Journal:  Clin Microbiol Rev       Date:  2020-06-24       Impact factor: 26.132

Review 4.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

5.  What We Need to Consider During and After the SARS-CoV-2 Pandemic.

Authors:  Willy A Valdivia-Granda; Jürgen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2020-05-29       Impact factor: 2.133

6.  Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.

Authors:  Anastasia N Vlasova; Xinsheng Zhang; Mustafa Hasoksuz; Hadya S Nagesha; Lia M Haynes; Ying Fang; Shan Lu; Linda J Saif
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

7.  Bovine-like coronaviruses isolated from four species of captive wild ruminants are homologous to bovine coronaviruses, based on complete genomic sequences.

Authors:  Konstantin P Alekseev; Anastasia N Vlasova; Kwonil Jung; Mustafa Hasoksuz; Xinsheng Zhang; Rebecca Halpin; Shiliang Wang; Elodie Ghedin; David Spiro; Linda J Saif
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

Review 8.  Review of bats and SARS.

Authors:  Lin-Fa Wang; Zhengli Shi; Shuyi Zhang; Hume Field; Peter Daszak; Bryan T Eaton
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

Review 9.  Animal models for COVID-19.

Authors:  César Muñoz-Fontela; William E Dowling; Simon G P Funnell; Pierre-S Gsell; A Ximena Riveros-Balta; Randy A Albrecht; Hanne Andersen; Ralph S Baric; Miles W Carroll; Marco Cavaleri; Chuan Qin; Ian Crozier; Kai Dallmeier; Leon de Waal; Emmie de Wit; Leen Delang; Erik Dohm; W Paul Duprex; Darryl Falzarano; Courtney L Finch; Matthew B Frieman; Barney S Graham; Lisa E Gralinski; Kate Guilfoyle; Bart L Haagmans; Geraldine A Hamilton; Amy L Hartman; Sander Herfst; Suzanne J F Kaptein; William B Klimstra; Ivana Knezevic; Philip R Krause; Jens H Kuhn; Roger Le Grand; Mark G Lewis; Wen-Chun Liu; Pauline Maisonnasse; Anita K McElroy; Vincent Munster; Nadia Oreshkova; Angela L Rasmussen; Joana Rocha-Pereira; Barry Rockx; Estefanía Rodríguez; Thomas F Rogers; Francisco J Salguero; Michael Schotsaert; Koert J Stittelaar; Hendrik Jan Thibaut; Chien-Te Tseng; Júlia Vergara-Alert; Martin Beer; Trevor Brasel; Jasper F W Chan; Adolfo García-Sastre; Johan Neyts; Stanley Perlman; Douglas S Reed; Juergen A Richt; Chad J Roy; Joaquim Segalés; Seshadri S Vasan; Ana María Henao-Restrepo; Dan H Barouch
Journal:  Nature       Date:  2020-09-23       Impact factor: 49.962

Review 10.  Current vaccine technology with an emphasis on recombinant measles virus as a new perspective for vaccination against SARS-CoV-2.

Authors:  Rim Jbeli; Awatef Jelassi
Journal:  EuroMediterr J Environ Integr       Date:  2021-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.